corresponding iodomethyl compound. This, in turn, could
be used as an electrophile for the preparation of a variety
of C-septanoside conjugates.
Scheme 1. Synthesis of C-Septanoside 4 via Vinylation and
Electrophilic Cyclization
Our implementation of the strategy is illustrated using
tetra-O-benzyl-D-glucose 1 in Scheme 1. Addition of vinyl
magnesium bromide to 1 gave a 3:2 mixture of diastereo-
meric allylic alcohols (78% combined yield). In our hands,
the yield and selectivity of the addition were slightly lower
than has been reported;12,14 the procedure was sufficient
enough, however, to obtain material for the subsequent
reactions without optimization. The major isomer, 2, was
treated with Hg(OTFA)2 in THF followed by I2 in DCM.
The product of the two-step process, to our delight, was
iodomethyl compound 3 which was obtained in 53% yield
over the two steps. At this stage, the stereochemistry of the
newly created stereocenter at C2 (glycosidic numbering)
was uncertain. To facilitate characterization of the stereo-
chemistry of the new compound, we chose to dehalogenate
the iodomethyl group and also to convert the benzyl
protecting groups to acetates via hydrogenation and acetyla-
tion, which gave C-septanoside 4 in 92% yield. The 13C and,
importantly, 1H NMR spectra for 4 were simpler to interpret
in comparison to 3. Diagnostic cross-peaks in the NOESY
spectrum of 4 (CDCl3) between H1ꢀH2, H1ꢀH4, and
H1ꢀH6 were considered diagnostic for the cis-1,2 “β” config-
3
uration shown in Scheme 1. Additionally, the low JH1,H2
coupling (3.3 Hz) constant also supported the cis configura-
tion of protons at the C1 and C2 positions. The minor isomer
of vinyl addition to glucose, which is epimeric at the allylic
alcohol carbon relative to 2, was subjected to the same reaction
sequence; analysis of NMR spectra of the product, as had
been done for characterization of 4 previously, led to assign-
ment of cis-1,2 C-septanoside 5 as the structure (Figure 1).15
Through the same set of reactions, tetra-O-benzyl-D-galactose
was converted to 6 and 7, respectively.12,16 Moreover, our
structural assignment of 4ꢀ7was fortified by the inside alkoxy
model for that rationalizes stereoselectivity for additions to
chiral allylic systems.17,18
Figure 1. Products (4ꢀ7) of vinylationꢀcyclization sequence in
the D-gluco and D-galacto series.
generation of the enitol by Wittig olefination of a pyranose10
or vinyl addition to a pentose followed by Hg2þ cycliza-
tion.11 This strategy was originally utilized to stereoselec-
tively prepare R-D-C-glucopyranose derivatives and later
other, rarer C-glycosyl compounds. Since then, it has been
used to prepare numerous biologically active C-glycosyl
derivatives.12 The key question to us (Scheme 1) was
whether the cyclization of species such as 2 to form a
seven-membered ring would be favored over other reac-
tions (e.g., intermolecular etherification, intramolecular
attack of a benzyl ether, etc.). There is ample literature
precedent for the addition of vinyl Grignards to aldo-
hexoses.13 Cyclization using Hg2þ as an electrophile would
give analkyl mercury species that could be convertedtothe
Stereoselectivity in the cyclization reaction is linked to
the absolute configuration at the allylic carbon. The π-bond
is nucleophilic when it is coplanar with the CꢀO bond of
the allylic carbon (e.g., I or II) because, in this conforma-
tion, its electron density is localized on the π-bond itself
rather than delocalized into the σ* of the CꢀO bond.16,17
(10) (a) Pougny, J. R.; Nassar, M. A. M.; Sinay, P. J. Chem. Soc.,
Chem. Commun. 1981, 375–376. (b) Nicotra, F.; Panza, L.; Ronchetti,
F.; Russo, G.; Toma, L. Carbohydr. Res. 1987, 171, 49–57. (c) Beaton,
S. A.; Huestis, M. P.; Sadeghi-Khomami, A.; Thomas, N. R.; Jakeman,
D. L. Chem. Commun. 2009, 238–240.
(11) (a) Boschetti, A.; Nicotra, F.; Panza, L.; Russo, G. J. Org. Chem.
1988, 53, 4181–4185. (b) Zahra, J.; Hennig, L.; Findeisen, M.; Giesa, S.;
Welzel, P.; Muller, D.; Sheldrick, W. S. Tetrahedron 2001, 57, 9437–9452.
(12) (a) Hans, S. K.; Camara, F.; Altiti, A.; Martin-Montalvo
Sanchez, A.; Brautigan, D. L.; Heimark, D.; Larner, J.; Grindrod, S.;
Brown, M. L.; Mootoo, D. R. Bioorg. Med. Chem. 2010, 18, 1103–1110.
(b) Nolen, E. G.; Kurish, A. J.; Potter, J. M.; Donahue, L. A.; Orlando,
M. D. Org. Lett. 2005, 7, 3383–3386. (c) Caravano, A.; Vincent, S. P.
Eur. J. Org. Chem. 2009, 1771–1780.
(14) Monrad, R. N.; Madsen, R. Tetrahedron 2011, 67, 8825–8850.
(15) Cyclization products en route to and including 5 have ∼10%
inseparable impurity which we have tentatively been assigned as the 1,2-
trans product. More details are in the Supporting Information.
(16) The Supporting Information contains details on the synthesis of
compounds 5ꢀ7.
(17) Chamberlin, A. R.; Mulholland, R. L.; Kahn, S. D.; Hehre, W. J.
J. Am. Chem. Soc. 1987, 109, 672–677.
ꢀ
€
(13) (a) Cribiu, R.; Borbas, E.; Cumpstey, I. Tetrahedron 2009, 65,
(18) Houk, K. N.; Moses, S. R.; Wu, Y.-D.; Rondan, N. G.; Jager,
ꢀ
2022–2031. (b) Cribiu, R.; Cumpstey, I. Chem. Commun 2008, 1246–1248.
V.; Schohe, R.; Fronczek, F. R. J. Am. Chem. Soc. 1984, 106, 3880–3882.
B
Org. Lett., Vol. XX, No. XX, XXXX